Paeonol
CAS No. 552-41-0
Paeonol( 2'-Hydroxy-4'-methoxyacetophenone | NSC 401442 )
Catalog No. M15001 CAS No. 552-41-0
Paeonol (Peonol), a phenolic compound extracted from Chinese herbs Paeonia suffruticosa (moutan cortex) and Cynanchum paniculatum, inhibits MAO with an IC50 of about 50 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 41 | Get Quote |
|
| 1G | 58 | Get Quote |
|
Biological Information
-
Product NamePaeonol
-
NoteResearch use only, not for human use.
-
Brief DescriptionPaeonol (Peonol), a phenolic compound extracted from Chinese herbs Paeonia suffruticosa (moutan cortex) and Cynanchum paniculatum, inhibits MAO with an IC50 of about 50 μM.
-
DescriptionPaeonol (Peonol), a phenolic compound extracted from Chinese herbs Paeonia suffruticosa (moutan cortex) and Cynanchum paniculatum, inhibits MAO with an IC50 of about 50 μM.(In Vitro):Paeonol is found to be inhibitory against MAO A in a dose-dependent manner with IC50 value of 54.6 μM. Paeonol is shown to inhibit MAO-B in a dose-dependent manner with the IC50 of 42.5 μM. For Paeonol, the Ki is estimated to be 51.1 μM. The inhibition of Paeonol on MAO B is of competitive type with Ki value of 38.2 μM.(In Vivo):The 200 mg/kg Paeonol+I/R group [AN/V (%): 7.6±2.2, p<0.01] and 100 mg/kg Paeonol+I/R group [AN/V (%): 9.4±2.8, p<0.05] both show lesser extents of no-reflow area in the ventricles compared with the I/R group [AN/V (%): 18.2±2.9]. In particular, the 200 mg/kg Paeonol + I/R group experienced markedly alleviated no-reflow in the whole heart [AN/WH (%): 4.6±1, p<0.05] compared with the I/R group [AN/WH (%): 10.0±1.9].
-
In VitroPaeonol is found to be inhibitory against MAO A in a dose-dependent manner with IC50 value of 54.6 μM. Paeonol is shown to inhibit MAO-B in a dose-dependent manner with the IC50 of 42.5 μM. For Paeonol, the Ki is estimated to be 51.1 μM. The inhibition of Paeonol on MAO B is of competitive type with Ki value of 38.2 μM.
-
In VivoThe 200 mg/kg Paeonol+I/R group [AN/V (%): 7.6±2.2, p<0.01] and 100 mg/kg Paeonol+I/R group [AN/V (%): 9.4±2.8, p<0.05] both show lesser extents of no-reflow area in the ventricles compared with the I/R group [AN/V (%): 18.2±2.9]. In particular, the 200 mg/kg Paeonol + I/R group experienced markedly alleviated no-reflow in the whole heart [AN/WH (%): 4.6±1, p<0.05] compared with the I/R group [AN/WH (%): 10.0±1.9].
-
Synonyms2'-Hydroxy-4'-methoxyacetophenone | NSC 401442
-
PathwayMetabolic Enzyme/Protease
-
TargetMAO
-
RecptorMAO-A| MAO-B
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number552-41-0
-
Formula Weight166.17
-
Molecular FormulaC9H10O3
-
Purity>98% (HPLC)
-
SolubilityEthanol: 33 mg/mL (198.59 mM); DMSO: 33 mg/mL (198.59 mM)
-
SMILESCC(C1=CC=C(OC)C=C1O)=O
-
Chemical Name1-(2-Hydroxy-4-methoxyphenyl)ethanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kong LD, et al. J Ethnopharmacol, 2004, 91(2-3), 351-355.
molnova catalog
related products
-
AnnH31
AnnH31 is a potent Dyrk1A inhibitor with an IC50 value of 81 nM.AnnH31 inhibits MAO-A with an IC50 of 3.2 μM.AnnH31 can be used as a probe to confirm the involvement of DYRK1A in cellular phosphorylation.
-
Modaline sulfate
Modaline, 2-methyl-3-piperidinopyrazine derivative, was found to inhibit monoamine oxidase (MAO) and showed therapeutic anti-depressant activity.
-
Esuprone
Esuprone (LU-43839) is a novel reversible and highly selective MAO-A inhibitor with anticonvulsant activity for the treatment of depression.
Cart
sales@molnova.com